Cytokinetics Inc vs Uber Technologies Inc — how do they compare? Cytokinetics Inc trades at $82.49 (market cap $11.16B), while Uber Technologies Inc trades at $72.56 (market cap $151.16B). The key difference: Uber Technologies Inc is far larger — about 13.5× Cytokinetics Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Uber Technologies Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | UBER | |
|---|---|---|
Market Cap | $11.16B | $151.16B |
Sector | Technology | Industrials |
52-Week High | $87.26 | $100.10 |
52-Week Low | $33.23 | $68.61 |
Enterprise Value | $11.63B | $157.49B |
Trailing returns across standard periods
Latest headlines on both assets
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →